Feasibility, and barriers to use escitalopram in functional gastrointestinal disorders
Background and study aims: The feasibility and barriars of escitalopram use in patients with functional gastrointestinal disorders (FGIDs) are still debated. We aimed to evaluate the feasibility, safety and efficacy and barriars of escitalopram use in managing FGIDs in the Saudi population.Patients...
Main Authors: | Saad S. Alkhowaiter, Amani H. Alshahrani, Hala F. Almarzouqi, Gadah K. Alonazi, Tariq M. Alhawassi, Maha M. AlRasheed |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1131354/full |
Similar Items
-
Dietary Patterns in Runners with Gastrointestinal Disorders
by: Kelly Anne Erdman, et al.
Published: (2021-01-01) -
Colorectal Cancer in Patient with Functional Gastrointestinal Symptoms
by: Z. A. Mamieva, et al.
Published: (2022-01-01) -
Escitalopram in patients with psoriasis
by: M. Artemieva, et al.
Published: (2021-04-01) -
Association of Functional Gastrointestinal Disorders with Adolescent Idiopathic Scoliosis
by: Soo-Bin Lee, et al.
Published: (2024-01-01) -
Female sexual dysfunction and Escitalopram antidepressant
by: Ali Mahran, et al.
Published: (2022-01-01)